Floatz logo

Wild-Type Reovirus

Childhood Atypical Teratoid/Rhabdoid Tumor

Mayo ClinicPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Childhood Atypical Teratoid/Rhabdoid Tumor cohort.

Asset / SponsorPhaseRating
Tazemetostat
Epizyme, Inc.
Phase 2B
Thalidomide
Medical University of Vienna
Phase 2CCC
Cyclophosphamide
Medical University of Vienna
Phase 2CCC
Fenofibric Acid
Medical University of Vienna
Phase 2CCC
ETOPOSIDE
Medical University of Vienna
Phase 2CCC

View all 39 →

Same molecule, other indications

Wild-Type Reovirus is also rated in:

exocrine pancreatic carcinomaDormant
B
Indicative ·
57 / 100
View asset →
pancreatic acinar cell carcinomaDormant
B
Indicative ·
57 / 100
View asset →
malignant pancreatic neoplasmDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →